Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation-Reply.
作者信息
Kotecha Dipak
机构信息
University of Birmingham Institute of Cardiovascular Sciences, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England.
出版信息
JAMA. 2021 Apr 27;325(16):1681-1682. doi: 10.1001/jama.2021.2676.
PMID:33904873
Abstract
摘要
相似文献
1
Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation-Reply.地高辛与比索洛尔用于控制心房颤动心率的比较——回复
JAMA. 2021 Apr 27;325(16):1681-1682. doi: 10.1001/jama.2021.2676.
2
Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation.地高辛与比索洛尔用于控制心房颤动患者的心率
JAMA. 2021 Apr 27;325(16):1680-1681. doi: 10.1001/jama.2021.2673.
3
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.地高辛与比索洛尔控制心房颤动患者心率对生活质量影响的比较：RATE-AF 随机临床试验。
JAMA. 2020 Dec 22;324(24):2497-2508. doi: 10.1001/jama.2020.23138.
4
In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.在永久性房颤和心衰的老年患者中，地高辛和比索洛尔在 6 个月时的生活质量方面没有差异。
Ann Intern Med. 2021 Jun;174(6):JC69. doi: 10.7326/ACPJ202106150-069. Epub 2021 Jun 1.
5
Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.β受体阻滞剂与地高辛用于控制房颤时的心室率
J Am Coll Cardiol. 2005 Jun 7;45(11):1905-6; author reply 1906-7. doi: 10.1016/j.jacc.2005.03.015.
6
Pharmacologic control of heart rate in atrial fibrillation.心房颤动时心率的药物控制
Cardiol Clin. 1996 Nov;14(4):521-36. doi: 10.1016/s0733-8651(05)70301-5.
7
Is there a role for digoxin in atrial fibrillation without heart failure?地高辛在无心力衰竭的心房颤动中是否有作用？
Cardiol J. 2009;16(5):483-6.
8
Is Digoxin Use Safe in Atrial Fibrillation? A Review of Contemporary Studies.
S D Med. 2016 Jul;69(7):322-323.
9
Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.将心房颤动心动过速的治疗从静脉注射β受体阻滞剂转换为比索洛尔透皮贴剂。
J Anesth. 2016 Oct;30(5):891-4. doi: 10.1007/s00540-016-2199-9. Epub 2016 Jun 4.
10
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.持续性心房颤动电复律后窦性心律的维持；索他洛尔与比索洛尔的比较
Eur Heart J. 2001 Aug;22(16):1504-10. doi: 10.1053/euhj.2000.2546.
引用本文的文献
1
Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020.过去二十年（2000-2020 年）疑似地高辛中毒和免疫 Fab 治疗的特征和结局。
Am J Cardiol. 2022 Nov 15;183:129-136. doi: 10.1016/j.amjcard.2022.08.004. Epub 2022 Sep 9.
Zotero 插件